Related Experiment Video
Updated: Jul 10, 2026
16:24
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Selective estrogen receptor modulators (SERMs) for uterine leiomyomas
1West China Hospital, Sichuan University, Chinese Cochrane Centre, Chinese EBM Centre, No. 37, Guo Xue Xiang, Chengdu, Sichuan, China, 610041. txwutx@hotmail.com
The Cochrane Database of Systematic Reviews
|October 19, 2007
Summary
Selective estrogen receptor modulators (SERMs) show a tendency for fibroid reduction but lack significant evidence. Further research is needed to confirm their effectiveness and safety in treating uterine fibroids.
Area of Science:
- Reproductive medicine
- Gynecology
- Pharmacology
Background:
- Uterine fibroids are common benign uterine tumors originating from smooth muscle cells.
- Selective estrogen receptor modulators (SERMs) are a class of drugs that interact with estrogen receptors.
- The efficacy of SERMs for uterine fibroid treatment remains controversial.
Purpose of the Study:
- To evaluate the evidence regarding the effectiveness and safety of SERMs in women diagnosed with uterine fibroids.
Main Methods:
- Comprehensive literature search across multiple databases including Cochrane Library, MEDLINE, and Chinese databases.
- Included randomized controlled trials comparing SERMs with other medical therapies or placebo in women aged 18-45.
- Data extraction and quality assessment by two independent reviewers; narrative synthesis due to study heterogeneity.
Main Results:
- Three studies with 215 participants were analyzed.
- SERMs demonstrated a trend towards fibroid size reduction, though not statistically significant across all studies.
- Adverse reactions were reported but lacked detailed data in the included studies.
Conclusions:
- Limited evidence suggests SERMs do not significantly reduce uterine fibroid size or improve clinical outcomes.
- Further rigorous studies are necessary to establish the therapeutic benefits of SERMs for uterine fibroids.
Related Concept Videos
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...